Business Context and Reporting Period
This Form 8-K Current Report is filed by MPLX LP for the reporting period of May 18, 2015. The filing discloses the execution of a Distribution Agreement to facilitate the potential sale of common units representing limited partner interests.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the authorization to raise capital through the sale of Common Units with an aggregate offering price of up to $500,000,000.
Material Changes
On May 18, 2015, MPLX LP and its General Partner, MPLX GP LLC, entered into a Distribution Agreement with J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, and Wells Fargo Securities, LLC. This agreement establishes an "at the market" offering program allowing the Partnership to sell Common Units through the Sales Agents at prevailing market prices.
Guidance, Outlook, and Terms
- Sales Method: Units may be sold via ordinary brokerage transactions on the NYSE, other national exchanges, electronic communication networks, or dark pools.
- Compensation: The Partnership will pay the Sales Agents a commission of up to 2% of the gross sales price per Common Unit, depending on volume.
- Expenses: The Partnership has agreed to reimburse certain expenses incurred by the Sales Agents.
- Registration: The offering is conducted pursuant to a shelf registration statement on Form S-3 (No. 333-203067) filed on March 27, 2015.
Investor Verification Checklist
- Verify the current market price of MPLX LP Common Units to assess the potential dilution impact of the $500 million offering capacity.
- Review the full text of the Distribution Agreement (Exhibit 1.1) for specific termination rights and conditions.
- Confirm the status of the Form S-3 registration statement (No. 333-203067) to ensure it remains effective for future sales.
- Monitor subsequent filings for actual sales volumes and proceeds generated under this agreement.